TNF and rheumatoid arthritis: We previously reported a significant elevation of ghrelin serum concentration upon a single infliximab infusion in RA patients with severe disease who despite receiving this anti-TNF-α agent had active disease with persistent elevation of laboratory markers of inflammation [27].